| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |